These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20036645)

  • 1. Class A scavenger receptor promotes osteoclast differentiation via the enhanced expression of receptor activator of NF-kappaB (RANK).
    Takemura K; Sakashita N; Fujiwara Y; Komohara Y; Lei X; Ohnishi K; Suzuki H; Kodama T; Mizuta H; Takeya M
    Biochem Biophys Res Commun; 2010 Jan; 391(4):1675-80. PubMed ID: 20036645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
    Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of osteoclast differentiation induced by IL-1.
    Kim JH; Jin HM; Kim K; Song I; Youn BU; Matsuo K; Kim N
    J Immunol; 2009 Aug; 183(3):1862-70. PubMed ID: 19587010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down-regulation of receptor activator of nuclear factor-kappaB and c-Fos.
    Grcević D; Lukić IK; Kovacić N; Ivcević S; Katavić V; Marusić A
    Clin Exp Immunol; 2006 Oct; 146(1):146-58. PubMed ID: 16968409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1.
    Urushibara M; Takayanagi H; Koga T; Kim S; Isobe M; Morishita Y; Nakagawa T; Löeffler M; Kodama T; Kurosawa H; Taniguchi T
    Arthritis Rheum; 2004 Mar; 50(3):794-804. PubMed ID: 15022321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4.
    Chang EJ; Kim HJ; Ha J; Kim HJ; Ryu J; Park KH; Kim UH; Lee ZH; Kim HM; Fisher DE; Kim HH
    J Cell Sci; 2007 Jan; 120(Pt 1):166-76. PubMed ID: 17164294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis.
    Merle B; Itzstein C; Delmas PD; Chenu C
    J Cell Biochem; 2003 Oct; 90(2):424-36. PubMed ID: 14505357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.
    Kamel Mohamed SG; Sugiyama E; Shinoda K; Hounoki H; Taki H; Maruyama M; Miyahara T; Kobayashi M
    Biochem Biophys Res Commun; 2005 Apr; 329(3):839-45. PubMed ID: 15752732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Regulatory mechanisms of osteoclast differentiation and function].
    Takahashi N
    Clin Calcium; 2006 Jun; 16(6):940-47. PubMed ID: 16751689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor activator of NF-kappaB ligand-stimulated osteoclastogenesis in mouse marrow culture is suppressed by zinc in vitro.
    Yamaguchi M; Uchiyama S
    Int J Mol Med; 2004 Jul; 14(1):81-5. PubMed ID: 15202020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor.
    Kubota T; Hoshino M; Aoki K; Ohya K; Komano Y; Nanki T; Miyasaka N; Umezawa K
    Arthritis Res Ther; 2007; 9(5):R97. PubMed ID: 17892600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor activator of nuclear factor-kappa B ligand induces osteoclast formation in RAW 264.7 macrophage cells via augmented production of macrophage-colony-stimulating factor.
    Islam S; Hassan F; Tumurkhuu G; Dagvadorj J; Koide N; Naiki Y; Yoshida T; Yokochi T
    Microbiol Immunol; 2008 Dec; 52(12):585-90. PubMed ID: 19120972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.
    Takahashi N; Udagawa N; Suda T
    Biochem Biophys Res Commun; 1999 Mar; 256(3):449-55. PubMed ID: 10080918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF kappa B and AP-1.
    Wattel A; Kamel S; Prouillet C; Petit JP; Lorget F; Offord E; Brazier M
    J Cell Biochem; 2004 May; 92(2):285-95. PubMed ID: 15108355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoclastogenesis is decreased by cysteine proteinase inhibitors.
    Brage M; Lie A; Ransjö M; Kasprzykowski F; Kasprzykowska R; Abrahamson M; Grubb A; Lerner UH
    Bone; 2004 Mar; 34(3):412-24. PubMed ID: 15003789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ly49Q, an ITIM-bearing NK receptor, positively regulates osteoclast differentiation.
    Hayashi M; Nakashima T; Kodama T; Makrigiannis AP; Toyama-Sorimachi N; Takayanagi H
    Biochem Biophys Res Commun; 2010 Mar; 393(3):432-8. PubMed ID: 20153723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
    Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
    Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
    Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
    J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors.
    Kwon OH; Lee CK; Lee YI; Paik SG; Lee HJ
    Biochem Biophys Res Commun; 2005 Sep; 335(2):437-46. PubMed ID: 16083856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
    Yi T; Lee HL; Cha JH; Ko SI; Kim HJ; Shin HI; Woo KM; Ryoo HM; Kim GS; Baek JH
    J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.